Conservative Treatment of Hemorrhoidal Disease

Author(s): Emanuela Stratta*, Gaetano Gallo, Mario Trompetto

Journal Name: Reviews on Recent Clinical Trials

Volume 16 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Hemorrhoids are vascular cushions underlying the distal rectal mucosa and contributing to approximately 15–20% of the resting anal pressure with a complete closure of the anal canal. They can become pathological (hemorrhoidal disease, HD) being the most common cause of painless rectal bleeding during defecation with or without prolapsing anal tissue. The treatment of HD must be tailored to both the severity of disease and patient’s expectation.

Methods: A narrative review of all the most relevant papers present on the three major databases (PUBMED, EMBASE and WEB OF SCIENCE) regarding conservative treatment was conducted.

Results: Conservative treatment is effective in managing the majority of patients complaining of early stages of the disease. Dietary and lifestyle modifications are the first therapeutic step necessary to achieve a regular defecation with soft stool whereas oral phlebotonic drugs can help to control symptoms. The use of topical medications, particularly during the acute phase or in the post-operative period can also be beneficial for all patients complaining of HD.

Conclusion: Despite a large number of available products in the market and the high incidence of HD, very few randomized controlled trials have been carried out and most of the studies are uncontrolled case series. Larger and better designed studies are necessary to establish the real benefit of all types of drugs for the treatment of early stages of HD.

Keywords: Hemorrhoids, hemorrhoidal disease, conservative treatment, non invasive, dietary, drugs.

[1]
Gallo G, Sacco R, Sammarco G. Epidemiology of hemorrhoidal disease.Hemorrhoids Coloproctology. Cham: Springer 2018; Vol. 2: pp. 3-7.
[http://dx.doi.org/10.1007/978-3-319-53357-5_1]
[2]
Goligher JC. Surgery of the anus, rectum and colon. London: Balliere Tindal 1980; pp. 93-135.
[3]
Picciariello A, Tsarkov PV, Papagni V, et al. Classifications and clinical assessment of haemorrhoids: The Proctologist’s Corner. Rev Recent Clin Trials 2020.
[http://dx.doi.org/10.2174/1574887115666200312163940] [PMID: 32164517]
[4]
Lohsiriwat V. Treatment of hemorrhoids: A coloproctologist’s view. World J Gastroenterol 2015; 21(31): 9245-52.
[http://dx.doi.org/10.3748/wjg.v21.i31.9245] [PMID: 26309351]
[5]
Gallo G, Martellucci J, Sturiale A. Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease. Tech Coloproctol 2020; 24(2): 145-64.
[6]
Sena G, Gallo G, Vescio G, et al. Excisional Haemorrhoidectomy: Where are we? Rev Recent Clin Trials 2020.
[http://dx.doi.org/10.2174/1574887115666200319153439] [PMID: 32189597]
[7]
Altomare DF, Giuratrabocchetta S. Conservative and surgical treatment of haemorrhoids. Nat Rev Gastroenterol Hepatol 2013; 10(9): 513-21.
[http://dx.doi.org/10.1038/nrgastro.2013.91] [PMID: 23752820]
[8]
Sielezneff I, Antoine K, Lécuyer J, et al. Is there a correlation between dietary habits and hemorrhoidal disease?. Presse Med 1998; 27(11): 513-7.
[PMID: 9767961]
[9]
Alonso-Coello P, Mills E, Heels-Ansdell D, et al. Fiber for the treatment of hemorrhoids complications: A systematic review and meta-analysis. Am J Gastroenterol 2006; 101(1): 181-8.
[http://dx.doi.org/10.1111/j.1572-0241.2005.00359.x] [PMID: 16405552]
[10]
Jones JR, Lineback DM, Levine MJ. Dietary reference intakes: implications for fiber labeling and consumption: A summary of the International Life Sciences Institute North American Fiber Workshop, June 1–2, 2004. Washington, DC. Nutr Rev 2006; 64: 31-8.
[http://dx.doi.org/10.1111/j.1753-4887.2006.tb00170.x] [PMID: 16491667]
[11]
US Department of Agriculture (USDA), US Department of Health and Human Services. Dietary Guidelines for Americans. Washington, DC: USDA 2005.
[12]
Berardi RR, Kroon LA, McDermott JH, et al. Handbook of Non prescription Drugs. 15th ed. Washington, DC: American Pharmacists Association 2006.
[13]
Garg P. Why should a good proportion of hemorrhoids not be operated on? - Let’s TONE Up. Dis Colon Rectum 2016; 59(6): 583-5.
[http://dx.doi.org/10.1097/DCR.0000000000000560] [PMID: 27145318]
[14]
Garg P, Singh P. Adequate dietary fiber supplement and TONE can help avoid surgery in most patients with advanced hemorrhoids. Minerva Gastroenterol Dietol 2017; 63(2): 92-6.
[PMID: 28150480]
[15]
Tan KY, Seow-Choen F. Fiber and colorectal diseases: separating fact from fiction. World J Gastroenterol 2007; 13(31): 4161-7.
[http://dx.doi.org/10.3748/wjg.v13.i31.4161] [PMID: 17696243]
[16]
Altomare DF, Rinaldi M, La Torre F, et al. Red hot chili pepper and hemorrhoids: The explosion of a myth: Results of a prospective, randomized, placebo-controlled, crossover trial. Dis Colon Rectum 2006; 49(7): 1018-23.
[http://dx.doi.org/10.1007/s10350-006-0532-3] [PMID: 16708161]
[17]
Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol 2012; 18(17): 2009-17.
[http://dx.doi.org/10.3748/wjg.v18.i17.2009] [PMID: 22563187]
[18]
Sikirov D. Comparison of straining during defecation in three positions: results and implications for human health. Dig Dis Sci 2003; 48(7): 1201-5.
[http://dx.doi.org/10.1023/A:1024180319005] [PMID: 12870773]
[19]
Alonso-Coello P, Zhou Q, Martinez-Zapata MJ, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg 2006; 93(8): 909-20.
[http://dx.doi.org/10.1002/bjs.5378] [PMID: 16736537]
[20]
Perera N, Liolitsa D, Iype S, et al. Phlebotonics for haemorrhoids. Cochrane Database Syst Rev 2012; (8): CD004322.
[http://dx.doi.org/10.1002/14651858.CD004322.pub3] [PMID: 22895941]
[21]
Tufano A, Arturo C, Cimino E, et al. Mesoglycan: Clinical evidences for use in vascular diseases. Int J Vasc Med 2010; 2010: 390643.
[http://dx.doi.org/10.1155/2010/390643] [PMID: 21152191]
[22]
Saggioro A, Chiozzini G. [Mesoglycan sulfate in acute hemorrhoidal pathology Minerva Med 1986; 77(41): 1909.
[PMID: 2946984]
[23]
Saggioro A, Chiozzini G, Pallini P, et al. [Treatment of hemorrhoidal crisis with mesoglycan sulfate Minerva Dietol Gastroenterol 1985; 31(2): 311-5.
[PMID: 3162110]
[24]
Gallo G, Mistrangelo M, Passera R, et al. Efficacy of mesoglycan in pain control after excisional hemorrhoidectomy: A pilot comparative prospective multicenter study. Gastroenterol Res Pract 2018; 2018: 6423895.
[http://dx.doi.org/10.1155/2018/6423895] [PMID: 29743886]
[25]
Johanson JF. Nonsurgical treatment of hemorrhoids. J Gastrointest Surg 2002; 6(3): 290-4.
[http://dx.doi.org/10.1016/S1091-255X(01)00081-6] [PMID: 12022975]
[26]
Sturiale A, Gallo G, Brusciano L, et al. Safety and efficacy of Proctosoll Allevia in the Management of Haemorrhoidal Disease in Adults: A prospective randomized clinical trial. Rev Recent Clin Trials 2020; 15(2): 152-9.
[http://dx.doi.org/10.2174/1574887115666200421110107] [PMID: 32316899]
[27]
Lodi A, Ambonati M, Coassini A, Kouhdari Z, Palvarini M, Crosti C. Contact allergy to ‘caines’ caused by anti-hemorrhoidal ointments. Contact Dermat 1999; 41(4): 221-2.
[http://dx.doi.org/10.1111/j.1600-0536.1999.tb06136.x] [PMID: 10515104]
[28]
Ramirez P, Sendagorta E, Floristan U, Feltes RA, Vidaurrazaga C. Allergic contact dermatitis from antihemorrhoidal ointments: concomitant sensitization to both amide and ester local anesthetics. Dermatitis 2010; 21(3): 176-7.
[http://dx.doi.org/10.2310/6620.2010.09094] [PMID: 20487666]
[29]
Altomare DF, Giannini I. Pharmacological treatment of hemorrhoids: A narrative review. Expert Opin Pharmacother 2013; 14(17): 2343-9.
[http://dx.doi.org/10.1517/14656566.2013.836181] [PMID: 24024752]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2021
Published on: 21 October, 2020
Page: [87 - 90]
Pages: 4
DOI: 10.2174/1574887115666201021150144
Price: $65

Article Metrics

PDF: 25
HTML: 3